Potassium%25252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252520chloride

# Potassium Chloride ## Overview Potassium chloride (KCl) is an essential electrolyte used to prevent or treat hypokalemia. It is available in various formulations including oral tablets, capsules, liquids, and intravenous solutions. ## Primary Indications * Treatment and prevention of hypokalemia. * Prevention of hypokalemia during thiazide or loop diuretic therapy. ## Adult Dosing * **Oral Prevention:** 20 mEq (10 mmol) per day, typically divided once or twice daily. * **Oral Treatment:** 40-100 mEq (20-50 mmol) per day, divided 2-4 times daily. * Maximum oral dose typically 200 mEq (100 mmol) per 24 hours, but higher doses may be used cautiously under close monitoring. * **Intravenous Treatment:** Dosing is highly individualized based on serum potassium levels and clinical status. * **Mild Hypokalemia (3.0-3.5 mEq/L):** 10-20 mEq (5-10 mmol) added to 1 L of IV fluid, infused over several hours. * **Moderate Hypokalemia (2.5-3.0 mEq/L):** 20-40 mEq (10-20 mmol) added to 1 L of IV fluid, infused over 2-4 hours. * **Severe Hypokalemia (<2.5 mEq/L):** May require higher doses and more rapid infusion, often via central venous access and continuous cardiac monitoring. Doses up to 40 mEq (20 mmol) per hour can be administered in emergencies. * **Maximum concentration for peripheral infusion:** Generally limited to 40 mEq/L to avoid phlebitis. Concentrations up to 80 mEq/L may be used via central venous access. * **Maximum daily dose:** Typically 200 mEq (100 mmol) per 24 hours, but higher may be needed in severe cases. ## Pediatric Dosing Dosing is weight-based and dependent on the degree of hypokalemia. General guidelines: * **Maintenance:** 1-2 mEq/kg/day (0.5-1 mmol/kg/day) orally, not to exceed 100 mEq (50 mmol) per day. * **Treatment:** 0.5-1 mEq/kg/dose (0.25-0.5 mmol/kg/dose) orally, administered over several hours, typically up to 3-4 doses per day. * **Intravenous:** Similar to oral, 0.5-1 mEq/kg/dose (0.25-0.5 mmol/kg/dose) infused over 3-6 hours. * Maximum infusion rate: 0.5 mEq/kg/hour (0.25 mmol/kg/hour) for peripheral administration, or up to 1 mEq/kg/hour (0.5 mmol/kg/hour) for central administration in severe cases with cardiac monitoring. * Maximum concentration: 40 mEq/L (20 mmol/L) for peripheral, 80 mEq/L (40 mmol/L) for central. ## Dose Adjustments * **Renal Impairment:** Use with extreme caution. Potassium levels can accumulate rapidly. Dose reduction is often necessary, and frequent monitoring of electrolytes and renal function is critical. In severe renal impairment, potassium supplementation may be contraindicated. * **Adrenal Insufficiency:** Increased risk of hyperkalemia. ## Contraindications * Hyperkalemia (serum potassium > 5.0 mEq/L). * Conditions that predispose to hyperkalemia such as untreated Addison's disease, severe renal impairment, anuria, and certain types of heart block. * Gastrointestinal obstruction or delayed gastric emptying. ## Adverse Effects * **Most Common:** Gastrointestinal upset (nausea, vomiting, diarrhea, abdominal pain). Oral formulations can cause esophageal or gastric irritation/ulceration, especially if not taken with sufficient fluid. * **Serious:** Hyperkalemia (manifesting as muscle weakness, fatigue, paresthesias, cardiac arrhythmias, cardiac arrest), cardiac conduction abnormalities. ## Key Drug Interactions * **ACE Inhibitors, ARBs, Potassium-Sparing Diuretics (e.g., spironolactone, amiloride), NSAIDs, Heparin, Trimethoprim:** Increased risk of hyperkalemia. * **Succinylcholine:** May potentiate hyperkalemic effects. * **Digitalis Glycosides:** Hypokalemia can increase digitalis toxicity; conversely, hyperkalemia can decrease digitalis efficacy. ## Monitoring * Serum potassium levels (frequently, especially with IV administration, rapid titration, or in patients with renal impairment). * Renal function (BUN, creatinine). * ECG monitoring, especially with rapid IV infusion or severe hypokalemia/hyperkalemia. * Signs and symptoms of hypokalemia (muscle weakness, cramps) and hyperkalemia (arrhythmias, paresthesias). ## Clinical Pearls * Always dilute oral potassium chloride liquid formulations and administer with meals or immediately after to minimize GI irritation. * Ensure adequate urine output before administering IV potassium. * Potassium chloride should be administered slowly, especially intravenously, to prevent cardiac arrhythmias. Continuous cardiac monitoring is essential for rapid IV infusions. * Be aware that many salt substitutes contain potassium chloride and can contribute to increased intake. *** *Disclaimer: This information is intended for healthcare professionals and does not replace the need to consult the official prescribing information or other current drug compendia for complete and up-to-date details.*